(Q36132386)

12 August 2017

1 reference

title

The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis (English)

1 reference

12 August 2017

1 reference

Buttgereit F

1

1 reference

12 August 2017

Saag KG

2

1 reference

12 August 2017

Cutolo M

3

1 reference

12 August 2017

da Silva JA

4

1 reference

12 August 2017

Bijlsma JW

5

1 reference

12 August 2017

publication date

1 January 2005

1 reference

Scandinavian Journal of Rheumatology

12 August 2017

published in

1 reference

12 August 2017

volume

34

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

14-21

1 reference

Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Corticosteroid resistance in rheumatoid arthritis: molecular and cellular perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

The hsp90-based chaperone system: involvement in signal transduction from a variety of hormone and growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Pro-inflammatory role of serotonin and interleukin-6 in arthritis and spondyloarthropathies--measurement of disease activity by bone scan and effect of steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Nongenomic actions of steroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Rapid glucocorticoid effects on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Intravenous pulses of methylprednisolone for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Treatment of Behçet's disease--an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Glucocorticoids in the treatment of early and late RA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Glucocorticoid resistance in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Glucocorticoid receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Glucocorticoid receptor downregulation in early diagnosed rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Folding and stability of the ligand-binding domain of the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

RAP46 is a negative regulator of glucocorticoid receptor action and hormone-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Generation of innovative anti-inflammatory and anti-arthritic glucocorticoid derivatives that release NO: the nitro-steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

Molecular origins for the dominant negative function of human glucocorticoid receptor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

5'UTR sequences of the glucocorticoid receptor 1A transcript encode a peptide associated with translational regulation of the glucocorticoid receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F03009740510017706

10.1080/03009740510017706

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference